Quidelortho (QDEL) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Quidelortho Corp  (NASDAQ: QDEL)


Quidelortho's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QDEL Gross Profit Margin (Sep 27 2026)
Q3 		(Jun 28 2026)
Q2 		(Mar 29 2026)
Q1 		(Dec 28 2025)
Q4 		(Sep 28 2025)
Q3
Y / Y Revenue Change -11.57 %
Seq. Revenue Change -1.9 %
Revenue In Millions $618.90
Gross Profit Margin 46.79 %
Gross Profit Margin Total Ranking # 1996
Gross Profit In Millions $289.60
Y / Y Gross Profit Change -13.71 %
Seq. Gross Profit Change 6.12 %


Commenting Third Quarter 2026 Gross Profit Margin
Quidelortho Corp achieved Gross Profit of $290 millions compare to Gross Loss of $272.90 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -1.9 % Quidelortho Corp managed to reduce Cost of Sales and increase Gross Profit by 6.12 % to $290 millions. Gross Profit Margin grew to 46.79 %, below company average Gross Profit Margin.


Observing third quarter 2026 results within In Vitro & In Vivo Diagnostic Substances industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1996, from total ranking in the previous quarter at 2088.
Learn about Gross Margin
QDEL's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 7
Healthcare Sector # 345
Overall # 1978

Gross Profit Margin Statistics
High Average Low
86.69 % 58.35 % 42.56 %
(Dec 31 2020)   (Mar 29 2026)


QDEL Gross Income Trends • More of QDEL's Profitabilty Ratios • QDEL Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
QDEL's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
QDEL's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for QDEL's Competitors
Gross Profit Margin Profit Margin for Quidelortho's Suppliers
Gross Profit Margin Profit Margin for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Gross Profit Growth
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 27 2026, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginSep 27 2026 MRQ Gross ProfitSep 27 2026 MRQ Revenue
Myriad Genetics Inc   67.93 %$ 137.700  Millions$ 202.700  Millions
Idexx Laboratories Inc  62.94 %$ 764.298  Millions$ 1,214.237  Millions
Lantheus Holdings Inc   62.43 %$ 243.412  Millions$ 389.913  Millions
Neogen Corporation  47.38 %$ 105.600  Millions$ 222.900  Millions
Quidelortho Corp  46.79 %$ 289.600  Millions$ 618.900  Millions
Alpha Teknova Inc   37.99 %$ 4.826  Millions$ 12.704  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.